Chemical and Biological Integrative Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul, 02792, Republic of Korea.
KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul, 02841, Republic of Korea.
Exp Mol Med. 2022 Oct;54(10):1652-1657. doi: 10.1038/s12276-022-00859-0. Epub 2022 Oct 3.
The ferritin nanocage is an endogenous protein that exists in almost all mammals. Its hollow spherical structure that naturally stores iron ions has been diversely exploited by researchers in biotherapeutics. Ferritin has excellent biosafety profiles, and the nanosized particles exhibit rapid dispersion and controlled/sustained release pharmacokinetics. Moreover, the large surface-to-volume ratio and the disassembly/reassembly behavior of the 24 monomer subunits into a sphere allow diverse modifications by chemical and genetic methods on the surface and inner cage of ferritin. Here, we critically review ferritin and its applications. We (i) introduce the application of ferritin in drug delivery; (ii) present an overview of the use of ferritin in imaging and diagnosis for biomedical purposes; (iii) discuss ferritin-based vaccines; and (iv) review ferritin-based agents currently in clinical trials. Although there are no currently approved drugs based on ferritin, this multifunctional protein scaffold shows immense potential in drug development in diverse categories, and ferritin-based drugs have recently entered phase I clinical trials. This golden shortlist of recent developments will be of immediate benefit and interest to researchers studying ferritin and other protein-based biotherapeutics.
铁蛋白纳米笼是一种存在于几乎所有哺乳动物中的内源性蛋白质。其天然储存铁离子的中空球形结构已被生物治疗学研究人员广泛利用。铁蛋白具有极好的生物安全性,纳米颗粒表现出快速分散和控制/持续释放的药代动力学特性。此外,由于 24 个单体亚基可以组装成球体,因此具有较大的表面积与体积比和拆卸/组装行为,这使得铁蛋白的表面和内部笼可以通过化学和遗传方法进行多样化修饰。在这里,我们批判性地回顾了铁蛋白及其应用。我们:(i)介绍了铁蛋白在药物传递中的应用;(ii)概述了铁蛋白在生物医学成像和诊断中的应用;(iii)讨论了基于铁蛋白的疫苗;以及(iv)综述了目前正在临床试验中的基于铁蛋白的药物。尽管目前没有基于铁蛋白的批准药物,但这种多功能蛋白质支架在不同类别的药物开发中具有巨大的潜力,并且基于铁蛋白的药物最近已进入 I 期临床试验。这一最新发展的黄金清单将对研究铁蛋白和其他基于蛋白质的生物治疗药物的研究人员立即产生益处和兴趣。